Key result
ANP4-23 reduces portal pressure ~15% in cirrhotic rats, driven by splanchnic vasoconstriction.
Why the study?
Does ANP4-23 alter haemodynamics, plasma ANP1-28 concentrations, and urinary sodium excretion in cirrhotic and normal rats?
Does ANP4-23 alter haemodynamics, plasma ANP1-28 concentrations, and urinary sodium excretion in cirrhotic and normal rats?
ANP4-23 induces splanchnic vasoconstriction and a portal hypotensive effect in cirrhotic rats, and increases plasma ANP1-28 concentrations without affecting sodium excretion.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for portal hypotensive therapy in cirrhosis; prospective human studies needed before clinical adoption.
AIMS: In cirrhosis, the effects of selective activation of atrial natriuretic peptide (ANP) R2-receptors on haemodynamics, endogenous ANP (ANP1-28) and sodium excretion are unknown. The aim of the present study was to examine the effects of selective activation of ANP-R2 receptors by ANP4-23 (a ring-deleted analogue of endogenous ANP) on haemodynamics, plasma ANP1-28 concentrations and urinary sodium excretion in conscious cirrhotic and normal rats. METHODS: Haemodynamics and sodium excretion were measured prior to and following administration of ANP4 23. Plasma ANP1-28 concentrations were also measured. RESULTS: In cirrhotic rats, ANP4-23 significantly decreased portal pressure and tributary blood flow by 15% and 25% respectively but significantly increased portal territory vascular resistance by 30%. Systemic and renal haemodynamics were not altered by ANP4-23. In normal rats, ANP4-23 did not significantly change splanchnic, renal and systemic haemodynamics. In both groups of rats, ANP4-23 increased plasma ANP1-28 concentrations but did not change sodium excretion. CONCLUSIONS: ANP4-23 administration induced splanchnic vasoconstriction in cirrhotic but not in normal rats. ANP4-23-elicited vasoconstriction caused a portal hypotensive effect in cirrhotic rats. Finally, in both groups, ANP4-23 caused an increase in plasma ANP1-28 concentrations but did not increase sodium excretion.
No takes yet. Share an insight, caveat, or question.
Moreau et al. (2000) studied Cirrhosis. ANP4-23 vs. Normal rats / baseline was evaluated on Haemodynamics, plasma ANP1-28 concentrations and urinary sodium excretion. ANP4-23 administration induced splanchnic vasoconstriction and decreased portal pressure by 15% in cirrhotic rats, but not in normal rats.
Synapse has enriched 10 related papers. Consider them for comparative context: